MetaCap

Replimune Group Cash Flow Statement

NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

19.07-0.16 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Replimune Group free cash flow

In fiscal 2026, Replimune Group generated -$280.3 million of operating cash flow and spent $4.2 million on capital expenditures. That left free cash flow of -$284.6 million.

Summary generated from market data by MetaCap's automated system. Methodology

Replimune Group cash flow statement (annual)

Replimune Group annual cash flow statement
Fiscal year (USD)FY 20262026-03-31FY 20252025-03-31FY 20242024-03-31FY 20232023-03-31FY 20222022-03-31FY 20212021-03-31FY 20192020-03-31FY 20192019-03-31FY 20182018-03-31FY 20172017-03-31
Net Income-313.94M-247.30M-215.79M-174.28M-118.04M-80.87M-52.63M-30.83M-19.70M7.70M
Net Income growth (YoY)————————-355.74%—
Depreciation & Amortization3.33M3.50M2.65M2.45M2.15M1.71M533.00K148.00K109.00K122.00K
Stock-Based Compensation32.27M35.04M34.13M28.13M24.25M11.79M7.74M2.73M812.00K208.00K
Change in Working Capital-5.17M9.69M-4.57M922.00K303.00K-2.74M-2.89M-681.00K1.29M-122.00K
Operating Cash Flow-280.34M-192.25M-185.47M-128.05M-82.18M-61.39M-60.55M-25.38M-16.01M-7.08M
Capital Expenditures-4.22M-6.69M-5.66M-2.27M-2.34M-2.39M-6.54M-2.60M-136.00K-238.00K
Investing Cash Flow310.84M-23.80M97.20M-142.50M-1.81M-188.78M-5.23M-65.94M-44.05M-238.00K
Debt Issued35.00M015.00M28.15M0—10.00M———
Debt Repaid————0-10.00M————
Financing Cash Flow66.29M252.40M16.28M311.30M6.60M372.46M100.17M101.39M54.75M15.00M
Net Change in Cash97.91M36.66M-72.07M40.64M-76.57M123.02M34.25M9.23M-3.01M6.27M
Free Cash Flow-284.57M-198.94M-191.13M-130.32M-84.52M-63.78M-67.09M-27.98M-16.15M-7.32M

This table shows 10 annual periods of Replimune Group's cash flow statement, from FY 2026 back to FY 2017, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow REPL's reporting calendar. What is a cash flow statement?

More financial data